Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hanchuan Zupa Granule for asthma control in chronic persistent bronchial asthma
ChiCTR2400086925Phase 4Completed
- Sponsor
- China-Japan Friendship Hospital
- Start
- Jul 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Hanchuan Zupa Granule in asthma (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Good asthma control rate. Started Jul 2024; status: completed.
02
Drugs
Hanchuan Zupa Granule
03
Conditions
asthma
Beyond the preview
Go deeper on ChiCTR2400086925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086925.